Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Gastroenterology. 2016 Feb 24;150(4):785–790. doi: 10.1053/j.gastro.2016.02.042

Table 2.

Common Clinical Datasets

Type of Data Included
Demographic information Age, sex, racial identity, socioeconomic status, occupation, marital status, education, family/friend contact
Alcohol consumption data Age at onset of drinking, estimated levels of consumption (expressed as g/d), patterns of recent drinking (time line follow-back), preferred beverages, frequency of binge drinking, prior attempts to stop drinking use of medications to reduce drinking, family history of alcohol abuse and liver disease, history of recurrent alcoholic hepatitis with relapse to drinking
General clinical data Standard liver tests (aspartate aminotransferase, alanine aminotransferase, bilirubin, international normalized ratio (INR), albumin, total protein); presence or development of encephalopathy or gastrointestinal bleeding, renal function (estimated GFR, creatinine, electrolytes), measures of metabolic syndrome (high-density lipoprotein cholesterol, cholesterol, triglyceride, low-density lipoprotein cholesterol, hemoglobin A1c); medications (including over-the-counter medications, herbals, dietary supplements, and probiotics); hepatitis B virus, hepatitis C virus, human immunodeficiency virus serology; antinuclear antibody; iron, ferritin, iron binding capacity; Lille score if steroids used
Measures of social stress Other behavioral disorders (dual diagnoses—depression, anxiety, posttraumatic stress disorder), socioeconomic stress (eg, scales from the Health and Retirement Study); smoking, use of other drugs of abuse (eg, cocaine)
Nutritional Recent weight change, ability to consume a nutritious diet after the diagnosis of alcoholic hepatitis is made, survey of nutritional status, caffeine use (coffee, tea), cooking oil preference, nut consumption
Biobanking Whole blood, plasma/serum, urine, peripheral blood mononuclear cells, stool (bulk stool or mucosal swab), DNA, annotation about nutritional state (fed or fasting) when samples obtained.
Patient outcomes 30- and 90-day survival, work productivity, well-being, quality of life, World Health Organization Performance status, EQ5D, abstinence rates after discharge
Health economics data Cost of care (including acute hospital care and post-discharge care for alcohol addiction), length of hospital stay

NOTE. Some of these measures will only need to be obtained once (eg, family history, racial identity, education, DNA sample); others need to be tracked over time (eg, diet, alcohol use, medications, and illicit drugs).